67 related articles for article (PubMed ID: 1970571)
1. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells.
Chambers TC; McAvoy EM; Jacobs JW; Eilon G
J Biol Chem; 1990 May; 265(13):7679-86. PubMed ID: 1970571
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway.
Zhang J; Yu Z; You G
Acta Pharm Sin B; 2020 Jan; 10(1):186-194. PubMed ID: 31993315
[TBL] [Abstract][Full Text] [Related]
3. Linker Domains: Why ABC Transporters 'Live in Fragments no Longer'.
Ford RC; Marshall-Sabey D; Schuetz J
Trends Biochem Sci; 2020 Feb; 45(2):137-148. PubMed ID: 31839525
[TBL] [Abstract][Full Text] [Related]
4. Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions.
Crawford RR; Potukuchi PK; Schuetz EG; Schuetz JD
Drug Metab Dispos; 2018 May; 46(5):567-580. PubMed ID: 29514827
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.
Mayati A; Moreau A; Le Vée M; Stieger B; Denizot C; Parmentier Y; Fardel O
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375174
[TBL] [Abstract][Full Text] [Related]
6. Providing a molecular mechanism for P-glycoprotein; why would I bother?
Callaghan R
Biochem Soc Trans; 2015 Oct; 43(5):995-1002. PubMed ID: 26517914
[TBL] [Abstract][Full Text] [Related]
7. Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.
Kim CW; Asai D; Kang JH; Kishimura A; Mori T; Katayama Y
Tumour Biol; 2016 Feb; 37(2):1901-8. PubMed ID: 26323260
[TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.
Chaudhary P; Vishwanatha JK
Biochem Pharmacol; 2014 Oct; 91(4):457-73. PubMed ID: 25181458
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms underlying α-amanitin resistance in Drosophila melanogaster: a microarray analysis.
Mitchell CL; Saul MC; Lei L; Wei H; Werner T
PLoS One; 2014; 9(4):e93489. PubMed ID: 24695618
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?
Callaghan R; Luk F; Bebawy M
Drug Metab Dispos; 2014 Apr; 42(4):623-31. PubMed ID: 24492893
[TBL] [Abstract][Full Text] [Related]
11. Preparation of (99m)tc-clomiphene citrate as a novel agent for breast cancer imaging.
Ibrahim IT; Elkolally MT; Abd Elgany IY; Abd Albary A; Hodhod Elsayed M
ISRN Oncol; 2012; 2012():581281. PubMed ID: 23213567
[TBL] [Abstract][Full Text] [Related]
12. Current status on marine products with reversal effect on cancer multidrug resistance.
Abraham I; El Sayed K; Chen ZS; Guo H
Mar Drugs; 2012 Oct; 10(10):2312-2321. PubMed ID: 23170086
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ABC transporter function via phosphorylation by protein kinases.
Stolarczyk EI; Reiling CJ; Paumi CM
Curr Pharm Biotechnol; 2011 Apr; 12(4):621-35. PubMed ID: 21118091
[TBL] [Abstract][Full Text] [Related]
14. Protein kinases and multidrug resistance.
Rumsby MG; Drew L; Warr JR
Cytotechnology; 1998 Sep; 27(1-3):203-24. PubMed ID: 19002793
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the multidrug transporter, P-glycoprotein.
Germann UA; Chambers TC
Cytotechnology; 1998 Sep; 27(1-3):31-60. PubMed ID: 19002782
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine-mediated structural changes in the multidrug transporter P-glycoprotein: an intrinsic fluorescence quenching analysis.
Lima SA; Cordeiro-da-Silva A; de Castro B; Gameiro P
J Membr Biol; 2008 Jun; 223(3):117-25. PubMed ID: 18791834
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.
Miller DS; Bauer B; Hartz AM
Pharmacol Rev; 2008 Jun; 60(2):196-209. PubMed ID: 18560012
[TBL] [Abstract][Full Text] [Related]
18. A protein kinase Cbeta inhibitor attenuates multidrug resistance of neuroblastoma cells.
Svensson K; Larsson C
BMC Cancer; 2003 Mar; 3():10. PubMed ID: 12697075
[TBL] [Abstract][Full Text] [Related]
19. Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells.
Isonishi S; Ohkawa K; Tanaka T; Howell SB
Br J Cancer; 2000 Jan; 82(1):34-8. PubMed ID: 10638963
[TBL] [Abstract][Full Text] [Related]
20. BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.
de Lange EC; de Bock G; Schinkel AH; de Boer AG; Breimer DD
Pharm Res; 1998 Nov; 15(11):1657-65. PubMed ID: 9833984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
